36
Participants
Start Date
December 10, 2020
Primary Completion Date
January 14, 2021
Study Completion Date
February 3, 2021
Omeprazole 20 mg Capsules
Omeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the gastric mucosa, omeprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production
PT Pharma Metric Labs, Jakarta Pusat
PT Pharma Metric Labs
INDUSTRY
PT Kalbe Farma Tbk
INDUSTRY